Ignite Creation Date:
2025-12-24 @ 6:41 PM
Ignite Modification Date:
2026-02-23 @ 1:11 AM
Study NCT ID:
NCT06433557
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-07-02
First Post:
2024-05-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2 Clinical Trial to Evaluate Efficacy, Safety, and Tolerability of Navepegritide in Combination With Lonapegsomatropin in Children With Achondroplasia
Sponsor:
Ascendis Pharma Growth Disorders A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-07-26
Start Date Type:
ACTUAL
Primary Completion Date:
2025-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-09
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-23
First Submit QC Date:
None
Study First Post Date:
2024-05-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-01
Last Update Post Date:
2025-07-02
Last Update Post Date Type:
ACTUAL